AGT and cardiac hypertrophy: To investigate whether SMI could attenuate Ang II–induced cardiac hypertrophy, neonatal mouse cardiomyocytes were treated with SMI (1/4,000) and/or Ang II (0.8 μM) as described in the Materials and Methods section.